• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用一个金属环戊二烯二吡啶并吩嗪钌(II)配合物靶向细胞核 DNA。

Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex.

机构信息

MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, State Key Laboratory of Optoelectronic Materials and Technologies, School of Chemistry and Chemical Engineering, Sun Yat-Sen University , Guangzhou, 510275, China.

出版信息

J Med Chem. 2014 Nov 13;57(21):8971-83. doi: 10.1021/jm501095r. Epub 2014 Oct 23.

DOI:10.1021/jm501095r
PMID:25313823
Abstract

Recently, coordinatively saturated and substitutionally inert Ru(II) complexes have been investigated as anticancer agents. Herein a cyclometalated Ru(II) complex, Ru(bpy)(phpy)(dppz), was found to be rapidly taken up by cancer cells, and nearly 90% of the complex accumulated in the nuclei of cancer cells after a 2 h incubation. The anticancer activity of this complex was screened against a panel of cancer cell lines. Remarkably, it exhibited IC50 values that were an order of magnitude lower than those of cisplatin. This complex also displayed potencies superior to those of cisplatin against 3D tumor spheroids. Further studies revealed that the high DNA binding affinity of Ru(bpy)(phpy)(dppz) resulted in effective disruption of the binding of transcription factor NF-κB to DNA sequences, thereby inhibiting cellular transcription and leading to irreversible cancer cell apoptosis. Our work provides new insights into understanding the biological interactions and anticancer molecular mechanisms of DNA-specific Ru(II) polypyridyl complexes.

摘要

最近,配位饱和且取代惰性的 Ru(II) 配合物被研究作为抗癌剂。本文中,一种环金属化的 Ru(II) 配合物 [Ru(bpy)(phpy)(dppz)] (+) 被发现能够被癌细胞快速摄取,并且在孵育 2 小时后,几乎 90%的配合物积累在癌细胞的核内。该配合物的抗癌活性在一组癌细胞系中进行了筛选。值得注意的是,它表现出的 IC50 值比顺铂低一个数量级。该配合物对 3D 肿瘤球体的效力也优于顺铂。进一步的研究表明,[Ru(bpy)(phpy)(dppz)] (+) 与 DNA 的高结合亲和力导致转录因子 NF-κB 与 DNA 序列结合的有效破坏,从而抑制细胞转录并导致不可逆的癌细胞凋亡。我们的工作为理解 DNA 特异性 Ru(II) 多吡啶配合物的生物相互作用和抗癌分子机制提供了新的见解。

相似文献

1
Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium(II) complex.用一个金属环戊二烯二吡啶并吩嗪钌(II)配合物靶向细胞核 DNA。
J Med Chem. 2014 Nov 13;57(21):8971-83. doi: 10.1021/jm501095r. Epub 2014 Oct 23.
2
Novel cyclometalated Ru(II) complexes containing isoquinoline ligands: Synthesis, characterization, cellular uptake and in vitro cytotoxicity.新型含异喹啉配体的环金属化 Ru(II) 配合物的合成、表征、细胞摄取和体外细胞毒性。
Eur J Med Chem. 2020 Oct 1;203:112562. doi: 10.1016/j.ejmech.2020.112562. Epub 2020 Jul 15.
3
Comparison between polypyridyl and cyclometalated ruthenium(II) complexes: anticancer activities against 2D and 3D cancer models.多吡啶和环金属化钌(II)配合物的比较:针对二维和三维癌症模型的抗癌活性
Chemistry. 2015 Jan 7;21(2):715-25. doi: 10.1002/chem.201404922. Epub 2014 Nov 11.
4
Monomeric and dimeric coordinatively saturated and substitutionally inert Ru(ii) polypyridyl complexes as anticancer drug candidates.单核和二核配位饱和且取代惰性的 Ru(ii) 多吡啶配合物作为抗癌候选药物。
Chem Soc Rev. 2017 Nov 27;46(23):7317-7337. doi: 10.1039/c7cs00356k.
5
Synthesis, characterization, DNA interaction, antioxidant and anticancer activity studies of ruthenium(II) polypyridyl complexes.钌(II)多吡啶配合物的合成、表征、DNA 相互作用、抗氧化和抗癌活性研究。
J Photochem Photobiol B. 2013 Dec 5;129:48-56. doi: 10.1016/j.jphotobiol.2013.09.009. Epub 2013 Oct 15.
6
Dinuclear [{(p-cym)RuCl}2(μ-phpy)](PF6)2 and heterodinuclear [(ppy)2Ir(μ-phpy)Ru(p-cym)Cl](PF6)2 complexes: synthesis, structure and anticancer activity.双核[{(对异丙基苯)钌氯}₂(μ-苯基吡啶)](六氟磷酸根)₂和异双核[(二苯基吡啶)₂铱(μ-苯基吡啶)钌(对异丙基苯)氯](六氟磷酸根)₂配合物:合成、结构与抗癌活性
Dalton Trans. 2014 Oct 21;43(39):14546-9. doi: 10.1039/c4dt01033g.
7
Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes.利用金(III)模拟物克服顺铂耐药性:新型金(III)多吡啶配合物的抗癌活性。
J Inorg Biochem. 2012 Jan;106(1):32-42. doi: 10.1016/j.jinorgbio.2011.08.013. Epub 2011 Sep 12.
8
Cellular uptake, cytotoxicity, apoptosis, DNA-binding, photocleavage and molecular docking studies of ruthenium(II) polypyridyl complexes.钌(II)多吡啶配合物的细胞摄取、细胞毒性、凋亡、DNA结合、光裂解及分子对接研究
J Photochem Photobiol B. 2014 Mar 5;132:111-23. doi: 10.1016/j.jphotobiol.2014.02.003. Epub 2014 Feb 18.
9
Thiosemicarbazone Cu(II) and Zn(II) complexes as potential anticancer agents: syntheses, crystal structure, DNA cleavage, cytotoxicity and apoptosis induction activity.硫代卡巴腙铜(II)和锌(II)配合物作为潜在的抗癌剂:合成、晶体结构、DNA裂解、细胞毒性和凋亡诱导活性。
J Inorg Biochem. 2014 Jul;136:13-23. doi: 10.1016/j.jinorgbio.2014.03.004. Epub 2014 Mar 16.
10
Highly cytotoxic substitutionally inert rhodium(III) tris(chelate) complexes: DNA binding modes and biological impact on human cancer cells.高度细胞毒性的取代惰性铑(III)三(螯合物)配合物:与 DNA 的结合模式及对人癌细胞的生物学影响。
J Inorg Biochem. 2011 Jul;105(7):991-9. doi: 10.1016/j.jinorgbio.2011.04.006. Epub 2011 Apr 21.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Repurposing antimicrobials with ultrasound-triggered nanoscale systems for targeted biofilm drug delivery.利用超声触发的纳米级系统重新利用抗菌药物以实现靶向生物膜药物递送。
NPJ Antimicrob Resist. 2025 Apr 1;3(1):22. doi: 10.1038/s44259-025-00086-3.
3
A Novel Substituted Benzo[]quinoxaline-Based Cyclometalated Ru(II) Complex as a Biocompatible Membrane-Targeted PDT Colon Cancer Stem Cell Agent.
一种新型的基于苯并[]喹喔啉取代的环金属化钌(II)配合物作为生物相容性膜靶向光动力疗法结肠癌干细胞剂。
J Med Chem. 2024 Dec 12;67(23):21470-21485. doi: 10.1021/acs.jmedchem.4c02357. Epub 2024 Dec 2.
4
Investigation of the Relationship between Electronic Structures and Bioactivities of Polypyridyl Ru(II) Complexes.研究多吡啶钌(II)配合物的电子结构与生物活性之间的关系。
Molecules. 2023 Jun 27;28(13):5035. doi: 10.3390/molecules28135035.
5
Discovery of Ruthenium(II) Metallocompound and Olaparib Synergy for Cancer Combination Therapy.钌(II)金属配合物与奥拉帕利协同作用的发现及其在癌症联合治疗中的应用。
J Med Chem. 2023 May 25;66(10):6922-6937. doi: 10.1021/acs.jmedchem.3c00322. Epub 2023 May 15.
6
Assessment of toxicity and genotoxic safety profile of novel fisetin ruthenium-p-cymene complex in mice.新型漆黄素-对异丙基苯钌配合物对小鼠的毒性及遗传毒性安全性评估
Toxicol Res. 2022 Dec 12;39(2):213-229. doi: 10.1007/s43188-022-00158-w. eCollection 2023 Apr.
7
Highlights of New Strategies to Increase the Efficacy of Transition Metal Complexes for Cancer Treatments.提高过渡金属配合物治疗癌症疗效的新策略要点。
Molecules. 2022 Dec 29;28(1):273. doi: 10.3390/molecules28010273.
8
Ruthenium(II) Polypyridyl Complexes Containing Simple Dioxo Ligands: a Structure-Activity Relationship Study Shows the Importance of the Charge.含简单二氧配体的钌(II)多吡啶配合物:构效关系研究表明电荷的重要性。
Chembiochem. 2022 Oct 6;23(19):e202200398. doi: 10.1002/cbic.202200398. Epub 2022 Aug 26.
9
Metal Peptide Conjugates in Cell and Tissue Imaging and Biosensing.金属肽缀合物在细胞和组织成像及生物传感中的应用。
Top Curr Chem (Cham). 2022 Jun 15;380(5):30. doi: 10.1007/s41061-022-00384-8.
10
Unveiling the anti-cancer mechanism for half-sandwich and cyclometalated Ir(iii)-based complexes with functionalized α-lipoic acid.揭示具有功能化α-硫辛酸的半夹心和环金属化铱(III)配合物的抗癌机制。
RSC Adv. 2020 Feb 3;10(9):5392-5398. doi: 10.1039/c9ra10357k. eCollection 2020 Jan 29.